PATIENT INFORMATION LEAFLET
|
|
- Arthur Garrison
- 5 years ago
- Views:
Transcription
1 N-CORT 0.055% Nasal Spray For nasal use. PATIENT INFORMATION LEAFLET Active substance(s): Triamcinolone acetonide (w/w%) Excipient(s): Benzalkonium chloride 50%, sodium hydroxide, hydrochloric acid, EDTA disodium, polysorbate 80, Avicel RC 591, dextrose monohydrate and deionized water Read this PATIENT INFORMATION LEAFLET carefully before you start using this medicine, because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. If you go to a doctor or hospital during the use of this medicine, inform your doctor about this. Follow the instructions in this leaflet exactly. Do not use higher or lower doses than the dose which was recommended for you. What is in this leaflet 1. What N-CORT is and what it is used for 2. Before you use N-CORT 3. How to use N-CORT 4. Possible side effects 5. How to store N-CORT 1. What N-CORT is and what it is used for N-CORT contains triamcinolone acetonide as active substance. It is presented in a packaging containing 13.5 g suspension for 120 sprays with a measuring cup and a nasal applicator. Each dose contains 55 micrograms of triamcinolone acetonide. N-CORT is an antiallergic corticosteroid. It is used for the treatment of seasonal and perennial allergic rhinitis in adults and children at 2 years of age and older. 2. Before you use N-CORT Do not use N-CORT in the following conditions: If you or your children above 2 years of age are allergic to triamcinolone acetonide or to any of the other ingredients of this medicine. TAKE SPECIAL CARE WITH N-CORT in the following conditions If you or your children; are switching from current or previous long term systemic steroid therapy to N-CORT due to possible deterioration of the function of your suprarenal gland (adrenal). (Your doctor may want to follow up you closely in order to prevent acute renal insufficiency.) have fungal infection in your nose or larynx (In such cases your doctor will stop N-CORT treatment temporally and will give you required local therapy.) have experienced recent nasal ulcers, nasal surgery, or nasal trauma and not completely healed yet (Corticosteroids may delay wound healing.) If your child is under 2 years of age (There is not sufficient evidence on its efficacy and safety in children at this age.) 1
2 If the drug will be used in children or adolescents at high doses and for a long period (Corticosteroids, especially at high doses and long periods, have been reported to cause growth suppression in children and adolescents. Your doctor will closely monitor the results regarding the suppression of growth and will regularly measure the height of your children and determine the possible effects of the treatment on the growth rate.) have a change in vision or have had eye problems such as increased intraocular pressure, glaucoma, or cataracts. (Corticosteroids have been reported to cause such eye problems. Your doctor will perform regular eye examinations and follow you closely.) Please consult your doctor, even if these statements were applicable to you at any time in the past. Using N-Cort with food and drink: N-CORT is used as a nasal spray. It does not have any interactions with food and drinks due to its method of administration. Pregnancy Ask your doctor or pharmacist for advice before taking the medicine. If you are pregnant, you should not use N-CORT. Therefore, pregnancy status should be evaluated before initiation of the treatment. Your doctor may recommend you to use the medicine if he/she thinks that benefit to the mother justifies the potential risk to the fetus. If you notice that you are pregnant during treatment, please consult your doctor or pharmacist immediately. Breast-feeding Ask your doctor or pharmacist for advice before taking the medicine. If you have to take N-CORT during breast feeding, you should discontinue breast feeding in order to preserve the baby from small amounts of drug which excretes into human milk. Effects on ability to drive and use machines N-CORT has no known effect on the ability to drive or use machines. Important information about some of the ingredients of N-CORT N-CORT contains benzalkonium chloride as an excipient. This substance is an irritant, which may cause skin reactions. Using with other medicines There is no evidence showing interaction of N-CORT with any medicinal product. Please tell your doctor or pharmacist if you are taking or have recently taken any other prescription or nonprescription medicine. 3. How to use N-CORT Instructions for appropriate method and dose/frequency of administration: Your doctor will tell you how and in what dosage you should use your medicine. Adults and patients above 12 years of age; 2
3 The recommended starting dose is 220 mcg as two sprays in each nostril once daily. When symptoms have been controlled, the dose is reduced to 110 mcg as one spray in each nostril once a day. An improvement of symptoms may be seen at the first day after initiation of treatment in some patients. However, for maximum benefit several days of treatment may be necessary. Children between 6 and 12 years of age: The recommended dose is 110 mcg as 1 spray in each nostril once daily. In patients with more severe symptoms the dose of 220 mcg once daily may be used. Once symptoms have been controlled, treatment may be maintained at minimum effective dose. Children between 2 and 5 years of age: The recommended dose is 110 mcg as 1 spray in each nostril once daily. Maximum daily dose in this age group is 110 micrograms. Children younger than 2 years of age: There is not sufficient evidence on the efficacy and safety of the drug in children at this age group. Therefore it should not be used in children at this age group. Route and method of administration: N-CORT is used by intranasal route only and should be used regularly for optimal efficacy. Administration of N-CORT: N-CORT is used as a nasal spray only. 1. Push the white cover upwards and remove. Shake the bottle slowly before use. 2. Before using the Nasal Spray for the first time, hold it upright, push the top of it downwards and fill the pump and do this pumping 5 times until a fine spray appears. Spray is ready for use. 3
4 3. Close one of your nostrils by pressing with your finger. Hold the bottle upright and insert the spray tip into your nostril avoiding any discomfort. While your mouth is closed and breathing smoothly, push the top of the bottle and pump the spray. 4. Breathe in your mouth. 5. Repeat steps 3, 4 with the second nostril. 6. If you are 12 years of age or older, repeat steps 3, 4, 5 in order to pump 2 sprays for each nostril. For best results, the product should be used regularly. 7. After using the spray: Wipe the spray nozzle carefully with a soft cloth and close the bottle with dust cover. If you did not use the nasal spray for more than 2 weeks, you have to spray it once in the air before you start using it again. While you are doing this, hold the bottle so that the spray nozzle is pointing away from you. Shake well before each use. If the spray does not work, the nozzle may be blocked; clean it according to the following instructions. Do not try to unblock it. Do not enlarge the spray hole with a pin or other sharp object because this will destroy the spray mechanism. The nasal spray should be cleaned at least once a week or more often if it gets blocked. TO CLEAN THE SPRAY: l. Remove the dust cover and the spray nozzle that is shown in the picture only. Spray nozzle 2. Soak the spray nozzle and dust cover in warm water for a few minutes, and then rinse under cold running tap water. 3. Shake or tap off the excess water and allow air-drying. 4. Re-fit the spray nozzle. 4
5 5. Spray the unit until a fine mist is produced and use as usual. Starting from the first application, the bottle should be discarded after 120 sprays or in 2 months (13.5 g/packaging). Any remaining suspension should not be transferred to another bottle. Follow these instructions unless recommended otherwise by your doctor. Your doctor will tell you how long you will use N-CORT. Do not stop treatment earlier than you should, otherwise your symptoms may be seen again. Different age groups: Use in children: Children between 6 and 12 years of age: The recommended dose is 110 mcg as 1 spray in each nostril once daily. In patients with more severe symptoms the dose of 220 mcg once daily may be used. Once symptoms have been controlled, treatment may be maintained at minimum effective dose. Children between 2 and 5 years of age: The recommended dose is 110 mcg as 1 spray in each nostril once daily. Maximum daily dose in this age group is 110 micrograms. Children younger than 2 years of age: There is not sufficient evidence on the efficacy and safety of the drug in children at this age group. Therefore it should not be used in children at this age group. Use in elderly: The efficacy and safety of N-CORT in elderly patients have not been established. Special populations Kidney/liver failure: The safety and efficacy of N-CORT in the patients with kidney and liver failure have not been studied. If you have the impression that the effect of N-CORT is too strong or too weak, talk to your doctor or pharmacist. If you have used more N-CORT than you should: Acute overdose is not expected due to the active substance content of your drug. If you may have taken more N-CORT than you should, talk to a doctor or pharmacist. If you forget to use N-CORT: If you miss a dose and it is not very close to the time of the next dose, take the missed dose soon as you remember it. Do not use a double dose to make up for a forgotten dose. If you stop using N-CORT If you stop N-CORT without consulting to your doctor, your allergy symptoms may reoccur. 5
6 4. Possible side effects Like all medicines, side effects can occur in people sensitive to the contents of N-CORT. If any of the following occur stop using N-CORT and IMMEDIATELY inform your doctor or go to the nearest emergency department: Hypersensitivity reaction (difficulty in breathing, swelling of the throat) Generalized swelling of the skin on eyelids, around the mouth and hands and feet with itching These are all very serious side effects. If you have any of them, this means you have serious allergy to N-CORT. You may need emergency medical care or hospitalization. These very serious side effects occur very rarely. If you notice any of the following immediately inform your doctor or go to the nearest emergency department: Cataract Glaucoma Increased intraocular pressure Nose bleeding Cough Inflammation of the airways (bronchospasm) Tooth disorder These serious side effects occur very rarely. If you notice any of the following, inform your doctor: Drying of the mucous membrane of the nose and throat, nasal congestion and sneezing Inflammation of the intranasal mucous (rhinitis) Inflammation of pharynx (Pharyngitis) Flu syndrome Headache Dizziness Malaise Difficulty in breathing Insomnia Indigestion, abdominal pain Alterations in taste and smell, nausea Pharyngolaryngeal pain Diarrhea Exfoliation of the skin These are mild side effects of N-CORT. These side effects disappear when the dose is reduced or treatment is discontinued. If you notice any side effects not mentioned in this leaflet inform your doctor or pharmacist. 6
7 Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via clicking Reporting of Drug Side Effects icon on the website or Turkish Pharmacovigilance Center (TUFAM) by calling the phone number for side effects reporting line. By reporting side effects, you can help provide more information on the safety of this medicine. 5. How to store N-CORT Keep in the original package and out of the reach and sight of children. Store in room temperature under 25 C in dry place. Discard 2 months after opening N-CORT. Use in accordance with expiry date. Do not use N-CORT after the expiry date which is stated on the package. Marketing Authorization Holder: Berko İlaç ve Kimya San. A.Ş. Yenişehir Mah. Özgür Sok. No: Ataşehir/İstanbul (Pbx) (Fax) info@berko.com.tr Manufacturer: Berko İlaç ve Kimya San. A.Ş. Adil Mah. Yörükler Sok. No: 2 Sultanbeyli/İstanbul (Pbx) (Fax) This patient information leaflet was approved on 31/12/
PATIENT INFORMATION LEAFLET
N-CORT 0.055% nasal spray, suspension It is used by spraying into the nose. Active substance: (w/w%) Triamcinolone acetonide 0.055 PATIENT INFORMATION LEAFLET Excipients: Benzalkonium chloride 50%, sodium
More informationPATIENT INFORMATION LEAFLET
ALORES 2.5mg/5ml Syrup For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml syrup (1 spoon) contains desloratadine 2.5 mg. Excipient(s): Propylene glycol, sorbitol 70%, citric acid
More informationPATIENT INFORMATION LEAFLET
DROPOLEV 60 mg/ml oral drops, 30 ml For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each 1 ml solution contains 60 mg levodropropizine. Excipient(s): Methyl paraben sodium, propylene glycol,
More informationPATIENT INFORMATION LEAFLET
MAGNEZINC Film Coated Tablets For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each film tablet contains 30 mg zinc equivalent to 82.6 mg zinc sulfate monohydrate and 300 mg magnesium equivalent
More informationPATIENT INFORMATION LEAFLET
FERROZINC-G syrup, 100 ml For oral use PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml (1 spoon) syrup contains 40 mg iron (as ferrous gluconate) and 15 mg zinc (as zinc gluconate). Excipient(s):
More informationPATIENT INFORMATION LEAFLET
FERIFER-40 Oral Solution, 40 mg/5 ml For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each one spoon solution (5 ml) contains 40 mg of iron (as iron III polymaltose complex). Excipient(s):
More informationPATIENT INFORMATION LEAFLET
KLOBATE 0.05% cream For topical use. PATIENT INFORMATION LEAFLET Active substance(s): 0.05% clobetasol contains 17-propionate. Excipient(s): Stearyl alcohol, propylene glycol, vaseline, sorbitan sesquioleate,
More information2 What you need to know before you use Beconase. Package Leaflet: Information for the user
Package Leaflet: Information for the user Beconase Aqueous Nasal Spray beclometasone dipropionate 50 micrograms Read all of this leaflet carefully before you start using this medicine because it contains
More informationPATIENT INFORMATION LEAFLET
ZINCO-K 15 mg/5 ml syrup For oral use PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml syrup (1 spoon) contains 15 mg of zinc as zinc sulphate heptahydrate. Excipient(s): Sorbitol (%70), maltitol,
More informationPATIENT INFORMATION LEAFLET
HAMAZINC cream For topical use. PATIENT INFORMATION LEAFLET Active substance(s): Each 1 gram cream contains 53.5 mg hamamelis virginiana distillate and 180.00 mg zinc oxide. Excipient(s): Methylparaben(E218),
More informationPATIENT INFORMATION LEAFLET. Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine.
ALORES 2.5mg/5ml syrup For oral use only. PATIENT INFORMATION LEAFLET Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine. Excipients: Propylene glycol, sorbitol 70% (E420), citric
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION APO-TRIAMCINOLONE AQ Children 4 to 12 years Triamcinolone Acetonide Aqueous Nasal Spray 55 mcg/metered Spray Apotex Standard This leaflet is part III of a three-part Product
More information1 What Flixonase is and what it is used for
GSK logo Package Leaflet: Information For The User Flixonase Aqueous Nasal Spray fluticasone propionate 50 micrograms Read all of this leaflet carefully before you start using this medicine because it
More informationAllergy Relief 50 microgram Nasal Spray (Fluticasone propionate)
Information for the user Allergy Relief 50 microgram Nasal Spray (Fluticasone propionate) Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the user. Nasacort 55 micrograms/dose, nasal spray suspension Triamcinolone acetonide
Package leaflet: Information for the user 55 micrograms/dose, nasal spray suspension Triamcinolone acetonide Read all of this leaflet carefully before you start using this medicine because it contains
More informationPATIENT INFORMATION LEAFLET
HAMAZINC 5.35% + 18% cream For external use only. PATIENT INFORMATION LEAFLET Active substances: Each gram of cream contains; 53.5 mg hamamelis virginiana distillate and 180.00 mg zinc oxide. Excipients:
More informationPATIENT INFORMATION NASONEX [nā-zə-neks] 50 mcg (mometasone furoate monohydrate) Nasal Spray For Intranasal Use Only Read the Patient Information
PATIENT INFORMATION NASONEX [nā-zə-neks] 50 mcg (mometasone furoate monohydrate) Nasal Spray For Intranasal Use Only Read the Patient Information that comes with NASONEX before you start using it and each
More informationPackage leaflet: Information for the patient. Dymista Nasal Spray 137 micrograms / 50 micrograms per actuation Nasal Spray, Suspension
Package leaflet: Information for the patient Dymista Nasal Spray 137 micrograms / 50 micrograms per actuation Nasal Spray, Suspension Azelastine hydrochloride/fluticasone propionate Read all of this leaflet
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide
PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need
More informationTAFEN NASAL 50mcg nasal spray, suspension
PACKAGE LEAFLET: INFORMATION FOR THE USER TAFEN NASAL 50mcg nasal spray, suspension BUDESONIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPATIENT INFORMATION LEAFLET
ENFLUAT 0.4 % Sterile Eye Drops Applied dropwise to the eye. PATIENT INFORMATION LEAFLET Drug substance: Each 1ml contains 4 mg ketorolac tromethamine. Excipient(s): Benzalconium chloride, sodium chloride,
More informationFluticasone propionate, 50 mcg per spray. Please read this leaflet carefully before you use FLIXONASE ALLERGY & HAYFEVER 24 HOUR.
FLIXONASE ALLERGY & HAYFEVER 24 HOUR Fluticasone propionate, 50 mcg per spray Consumer Medicine Information What is in this leaflet? Please read this leaflet carefully before you use FLIXONASE ALLERGY
More informationNASONEX Aqueous Nasal Spray 0.05% Mometasone Furoate Monohydrate
NASONEX Aqueous Nasal Spray 0.05% Mometasone Furoate Monohydrate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about NASONEX. It does not contain all
More informationPART III: CONSUMER INFORMATION
PART III: CONSUMER INFORMATION Pr DYMISTA (Azelastine hydrochloride and fluticasone propionate, Nasal Spray) This leaflet is part III of a three-part "Product Monograph" published when DYMISTA was approved
More informationPackage leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate
Package leaflet: Information for the user PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate Read all of this leaflet carefully before you start using this medicine
More informationRead all of this leaflet carefully before you start using this medicine.
PACKAGE LEAFLET: INFORMATION FOR THE USER Allergo-COMOD nasal spray 20 mg/ml Nasal spray, solution Active ingredient: sodium cromoglicate (Ph. Eur.) 1 spray of 0.14 ml of Allergo-COMOD nasal spray contains
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr AVAMYS fluticasone furoate nasal spray FOR NASAL USE ONLY This leaflet is part III of a three-part "Product Monograph" published when AVAMYS was approved for sale in Canada
More informationPRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate
Package leaflet: Information for the user PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Read all of this leaflet carefully before you start using this medicine because it contains important
More informationAzelastine Nasal Spray 1 mg / 1 ml
Package Leaflet: Information for the User Allergodil 0,1% nasal spray, solution Active substance: Azelastine hydrochloride Read all of this leaflet carefully because it contains important information for
More informationLYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution
PACKAGE LEAFLET: INFORMATION FOR THE USER LYSOBACT COMPLETE SPRAY (20 + 1.5 + 0.5) mg / ml Oromucosal spray, solution LYSOZYME, CETYLPYRIDINIUM, LIDOCAINE This leaflet is a copy of the Summary of Product
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Nasonex 50 micrograms/actuation Nasal Spray, suspension. Mometasone Furoate
PACKAGE LEAFLET: INFORMATION FOR THE USER Nasonex 50 micrograms/actuation Nasal Spray, suspension Mometasone Furoate Please read this leaflet carefully before you start using this medicine. - Keep this
More informationPackage leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac
Package leaflet: Information for the user NEVANAC 1 mg/ml eye drops, suspension Nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationSummary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT Beconase Hayfever nasal spray 50 micrograms per spray Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 100 mg spray contains beclometasone
More informationFlixonase TM Aqueous Nasal Spray
Flixonase TM Aqueous Nasal Spray To the Medical and Pharmaceutical Professions. Presentations Not all presentations are registered in every, country. Nasal spray, suspension. Indications Fluticasone Propionate
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for
PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If
More informationPackage leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide
Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the patient. xylometazoline hydrochloride
Package leaflet: Information for the patient /.../ 0.5 mg/ml nasal spray, solution /.../ 1 mg/ml nasal spray, solution xylometazoline hydrochloride Read all of this leaflet carefully before you start using
More informationPackage leaflet: Information for the user. Nasofan TM Aqueous 50 microgram Nasal Spray Suspension Fluticasone Propionate
Package leaflet: Information for the user Nasofan TM Aqueous 50 microgram Nasal Spray Suspension Fluticasone Propionate Read all of this leaflet carefully before you start using this medicine because it
More informationPackage leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine
Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because
More informationPackage Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone
Package Leaflet - Information for the User TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Read all of this leaflet carefully before you start using this medicine because it
More informationPATIENT INFORMATION LEAFLET. Excipients: Sorbitol 70% (E420), glycerol, hydroxyethyl cellulose, mint flavor, purified water.
HEKSOBEN gargle For oral rinse PATIENT INFORMATION LEAFLET Active substance: 100 ml solution contains 120 mg (0.12%) chlorhexidine digluconate and 150 mg (0.15%) benzydamine hydrochloride. Excipients:
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride Read all of this leaflet carefully before you start using this
More informationPackage Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac
Package Leaflet: Information for the user NEVANAC 3 mg/ml eye drops, suspension nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information
More information1. What Octostim Nasal Spray is and what it is used for
Package Leaflet: Information for the User Octostim 1.5 mg/ml Nasal Spray Desmopressin acetate Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationEasyhaler Beclometasone 200 micrograms/dose inhalation powder
Package Leaflet: Information for the user Easyhaler Beclometasone 200 micrograms/dose inhalation powder Beclometasone dipropionate Read all of this leaflet carefully before you start using this medicine
More informationPATIENT INFORMATION LEAFLET
Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PRED FORTE Sterile Eye Suspension, prednisolone acetate 10 mg/ml sterile eye suspension
More informationPATIENT INFORMATION LEAFLET. Nasoxyl nasal spray solution 1 mg/ml
PATIENT INFORMATION LEAFLET Nasoxyl nasal spray solution 1 mg/ml Read all of this leaflet carefully, because it contains important information for you. This medicine is available without prescription.
More informationDorzolamide 20 mg/ml Eye Drops, Solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains
More informationPatient Information ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol. Do not use your ALVESCO Inhalation Aerosol near heat or an open flame.
Note: For Oral Inhalation Only Patient Information ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol Do not use your ALVESCO Inhalation Aerosol near heat or an open flame. Read this Patient Information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate
PACKAGE LEAFLET: INFORMATION FOR THE USER GRAZAX 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you
More informationPATIENT INFORMATION LEAFLET
DESIFEROL 2000 IU Film Coated Tablets For oral use only PATIENT INFORMATION LEAFLET Active substance(s): Each film coated tablet contains 2000 I.U. (50 ) vitamin D3 (derived from sheep wool). Excipient(s):
More informationDo not use Easyhaler Salbutamol if you are allergic (hypersensitive) to: Salbutamol lactose
Package leaflet: Information for the patient user Easyhaler Salbutamol Sulphate 100 and 200 micrograms/dose inhalation powder Salbutamol sulphate (salbutamol) Read all of this leaflet carefully before
More informationPackage leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin
Package leaflet: Information for the user 3 mg/ml eye drops, solution Ofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
More informationPATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops
Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Read all of this leaflet carefully
More informationPATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops
Page 1 of 5 SCHEDULING STATUS Schedule 2 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops Read all of this leaflet
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP Read this carefully before you start taking IOPIDINE 1% and each
More informationPackage leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate
Package leaflet: Information for the user Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the user. Nasonex 50 micrograms/actuation Nasal Spray, Suspension. Mometasone Furoate
Package leaflet: Information for the user Nasonex 50 micrograms/actuation Nasal Spray, Suspension Mometasone Furoate Please read this leaflet carefully before you start using this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Respules 1 mg/2 ml Nebuliser Suspension budesonide
PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Respules 1 mg/2 ml Nebuliser Suspension budesonide Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Xylo-COMOD
PACKAGE LEAFLET: INFORMATION FOR THE USER Xylo-COMOD Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you
More informationProposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate
Proposed PIL NL/H/0653/001/IB/024/G PACKAGE LEAFLET: INFORMATION FOR THE USER MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate Read all of this leaflet
More informationFASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER FASTUM 2.5% gel KETOPROFEN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines the
More informationPackage leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin
Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution Levofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Nasonal 1 mg/ml neusspray, oplossing. Xylometazoline hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Nasonal 1 mg/ml neusspray, oplossing Xylometazoline hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important
More informationVentolin Accuhaler 200 micrograms salbutamol sulfate
Package Leaflet: Information for the User Ventolin Accuhaler 200 micrograms salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate
Package leaflet: Information for the patient Brimonidine Biogaran 2 mg/ml eye drops, solution brimonidine tartrate Read all of this leaflet carefully before you start using this medicine because it contains
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET BEVIT-B12 film tablet For oral use. Active substance: Each film-coated tablet contains 250 mg pyridoxine hydrochloride (Vitamin B 6 ), 250 mg thiamine hydrochloride (Vitamin
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)
PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may
More informationPATIENT INFORMATION LEAFLET
Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 Proprietary name, Strength and Pharmaceutical Form LUMIGAN 0,03 % Eye Drops (each ml contains bimatoprost 0,3 mg) Read all of this leaflet
More informationINFORMATION FOR THE CONSUMER IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT
- 1 - INFORMATION FOR THE CONSUMER IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT PULMICORT NEBUAMP (budesonide suspension for inhalation) Before using PULMICORT NEBUAMP, read this leaflet carefully. It contains
More informationLUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)
LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about LUMIGAN eye drops. It does not contain all the available
More informationPackage leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin
Package leaflet: Information for the patient Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:
SCHEDULING STATUS: S2 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: TEXA 10 mg (tablets) TEXA SYRUP (syrup) Read this entire leaflet carefully before you start taking TEXA. Keep this leaflet. You
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Xylonase 0.1% w/v Nasal Spray, Solution Xylometazoline hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Xylonase 0.1% w/v Nasal Spray, Solution Xylometazoline hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone
PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You
More informationPackage leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)
Package leaflet: Information for the patient Loratadine 10 mg Tablets (loratadine) Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)
PACKAGE LEAFLET: INFORMATION FOR THE USER ZADITEN 1 mg/5 ml Oral Solution Ketotifen (as Ketotifen hydrogen fumarate) Read all of this leaflet carefully because it contains important information for you.
More informationNASONEX Aqueous Nasal Spray Mometasone Furoate. Schering-Plough
NASONEX Aqueous Nasal Spray Mometasone Furoate Schering-Plough COMPOSITION NASONEX Aqueous Nasal Spray is a metered-dose, manual pump spray unit containing a suspension of mometasone furoate. Each metered-dose
More informationPackage leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin
Package leaflet: Information for the patient Verkazia 1 mg/ml eye drops emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride
Package leaflet: Information for the patient / / 30 mg/5 ml syrup Ambroxol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationRABEPRAZOL 10mg and 20mg Gastro-resistant Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More informationTIMALEN 0.5% eye drops
PACKAGE LEAFLET: INFORMATION FOR THE USER TIMALEN 0.5% eye drops TIMOLOL (AS TIMOLOL MALEATE) This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPackage leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride
Package leaflet: Information for the user Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the patient. Eklira Genuair 322 micrograms inhalation powder Aclidinium (aclidinium bromide)
Package leaflet: Information for the patient Eklira Genuair 322 micrograms inhalation powder Aclidinium (aclidinium bromide) This medicine is subject to additional monitoring. This will allow quick identification
More informationPackage Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost
Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it
More informationPATIENT INFORMATION LEAFLET
Page 1 PATIENT INFORMATION LEAFLET Please read this leaflet carefully before using COMBIGAN. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Budesonide/Target 100mcg/dose, nasal spray suspension of fixed doses Budesonide
PACKAGE LEAFLET: INFORMATION FOR THE USER Budesonide/Target 100mcg/dose, nasal spray suspension of fixed doses Budesonide 1. IDENTIFICATIONS OF THE MEDICINAL PRODUCT 1.1. Trade name: Budesonide/Target
More informationPackage leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets
Package leaflet: Information for the patient Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets Acetylsalicylic acid Read all of this leaflet carefully before you
More informationPatient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA?
Patient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA? ARNUITY ELLIPTA is an inhaled corticosteroid (ICS) medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Beclometasone dipropionate
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Beclazone 50, 100, 250 micrograms Easi-Breathe CFC-Free Inhaler Pressurised Inhalation Solution Beclometasone dipropionate Read all of this leaflet carefully
More informationPackage leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid
Package leaflet: Information for the patient Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains
More informationHavrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe
GSK (logo) Package Leaflet: Information for the User Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed). 1440 ELISA Units/1 ml Suspension for Injection in a pre-filled syringe Read all
More informationPackage leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)
Package leaflet: Information for the user Colecalciferol 3000 IU/ml Oral Solution (colecalciferol) Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need
More informationPackage leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine
Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine Read all of this leaflet carefully before you start taking this medicine because
More informationPackage leaflet: Information for the user Easyhaler Salbutamol Sulfate 100 and 200 micrograms/dose inhalation powder Salbutamol sulfate (salbutamol)
Package leaflet: Information for the user Easyhaler Salbutamol Sulfate 100 and 200 micrograms/dose inhalation powder Salbutamol sulfate (salbutamol) Read all of this leaflet carefully before you start
More information